Specialized Medical Company — Cyborg Score 7/10

Solid
Healthcare Services / Medical Care Facilities

Strategic Profile

Founded in 1994 and headquartered in Riyadh, the company operates tertiary healthcare facilities with comprehensive surgical units and critical care capabilities. The company has demonstrated exceptional 22% five-year net income growth, positioning it as a growth-focused healthcare provider in an expanding regional healthcare market.

Cyborg Score Rationale

Market capitalization stands at approximately 4.97 billion SAR with 5.32% growth over the past week. Key financial indicators look decent with potential for long-term growth based on resilient fundamentals. Recent volatility and market pressure suggest room for improvement in execution.

Top Insights

  • EBITDA margin of 22.55% demonstrates operational efficiency in healthcare services delivery
  • Net income for latest quarter reached 66.25M SAR, showing 82.18% improvement quarter-over-quarter
  • Comprehensive service portfolio spanning surgical units, critical care, dermatology, aesthetic services, and dentistry
  • ROE aligns with industry average of 15%, indicating competitive operational efficiency

Named Competitors

  • Mouwasat Medical Services — Multi-facility healthcare network in Saudi Arabia
  • Dallah Healthcare — Comprehensive healthcare services and facilities
  • Fakeeh Care — Tertiary hospital and medical services provider

Recent Developments

  • (Dec 2025) Stock experienced 5.8% decline amid broader market weakness despite solid financial fundamentals
  • (Jan 2026) 52-week low of 17.30 SAR reached, reflecting recent market pressure
  • (Jun 2025) All-time high of 25.00 SAR achieved, indicating earlier strong market sentiment

Open the full interactive Specialized Medical Company report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →